PRKAR2A抗体PRKAR2A一抗抗体Protein ki
nase cAMP dependent regulatory type II alpha antibody抗体PRKAR2A Antibody抗体- ￥880 - 1320
- CUSABIO
- CN
- CSB-PA030232
- 2025年07月14日
- WB, IHC, IF, ELISA; WB:1:500-1:2000, IHC:1:100-1:300, IF:1:200-1:1000, ELISA:1:10000
- Rabbit
- Human
企业认证
相关产品推荐更多 >
IMPACT抗体IMPACT兔多抗抗体RWDD5 antibody抗体IMPACT Antibody, FITC conjugated抗体
￥880
MAGEA3抗体MAGEA3兔多抗抗体MGC1461 antibody抗体MAGEA3 Antibody, HRP conjugated抗体
￥880
BIN1抗体BIN1兔多抗抗体SH3P9 antibody抗体BIN1 Antibody抗体
￥440
HIST1H2BC抗体HIST1H2BC兔多抗抗体H2BFK抗体HIST1H2BC (Ab-120) Antibody抗体
￥440
OR4B1抗体OR4B1一抗抗体Olfactory receptor OR11-106抗体OR4B1 Antibody抗体
￥880
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Synthesized peptide derived from the Internal region of Human PKA IIα reg.
- 亚型：
IgG
- 形态：
Liquid
- 保存条件：
Upon receipt, store at -20℃ or -80℃. Avoid repeated freeze.
- 克隆性：
/
- 标记物：
Non-conjugated
- 适应物种：
Human
- 保质期：
6个月
- 抗原来源：
Homo sapiens (Human)
- 目录编号：
P13861
- 级别：
优
- 库存：
200
- 供应商：
武汉华美生物工程有限公司
- 宿主：
Rabbit
- 应用范围：
WB, IHC, IF, ELISA; WB:1:500-1:2000, IHC:1:100-1:300, IF:1:200-1:1000, ELISA:1:10000
- 浓度：
>95%,The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- 靶点：
PRKAR2A
- 抗体英文名：
PRKAR2A Antibody
- 抗体名：
Protein kinase cAMP dependent regulatory type II alpha antibody
- 规格：
100μg/50μg
| 规格： | 100μg | 产品价格： | ￥1320.0 |
|---|---|---|---|
| 规格： | 50μg | 产品价格： | ￥880.0 |
保存缓冲液
Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.功能
/风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验cAMP-dependent protein kinase (PKA) is involved in various cellular functions such as cell proliferation, gene induction, and metabolism (1 ,2 ) and its regulatory subunits have been suggested as a drug target for cancer and other diseases
motifs located prevalently in the 3′ untranslated regions of target messenger RNAs (mRNA). Interferon-alpha-2a (IFNα) induces a large set of protein coding genes mediating antiproliferative and antiviral responses. Here we use a global microarray-based
Two-hybrid analysis of genetic regulatory networks
to be involved in the disease. Recently, Reymond and Brent undertook a test of this idea (Reymond and Brent, 1995). They studied the protein encoded by the INK4 human tumor suppressor gene, p16. Wild type p16 interacts with two human Cyclin-dependent kinases, Cdk
技术资料暂无技术资料 索取技术资料
